Clari
ClariTrial
Built by Johnny Rice
Search
Explore
Companies
Targets
Safety
Pipeline
Competitive
Emerging
Map
Parsing your search query…
Explore
/
GLP-1 agonist obesity diabetes phases
Search
Status
Recruiting
Active
Not Yet
Completed
Terminated
Phase
Early Ph 1
Phase 1
Phase 2
Phase 3
Phase 4
N/A
1
results for
“GLP-1 agonist obesity diabetes phases”
NCT06234111
Active
Semaglutide and Physical Activity for Obesity and Multimorbidity
N/A
Obesity Morbid
Multimorbidity
Obesity
Semaglutide 2.4 mg, total diet replacement, behavioural intervention
Hvidovre University Hospital
35 participants
1 site · Denmark
Completes Oct 2026
More detail
Compare
CT.gov
Full analysis →
Previous
1–1 of 1
Next